ABT

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Abt Adverse Events Reported to the FDA Over Time

How are Abt adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Abt, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Abt is flagged as the suspect drug causing the adverse event.

Most Common Abt Adverse Events Reported to the FDA

What are the most common Abt adverse events reported to the FDA?

Febrile Neutropenia	45 (3.09%)
Thrombocytopenia	45 (3.09%)
Dehydration	44 (3.02%)
Nausea	34 (2.34%)
Vomiting	31 (2.13%)
Fatigue	30 (2.06%)
White Blood Cell Count Decreased	29 (1.99%)
Haemoglobin Decreased	24 (1.65%)
Pneumonia	24 (1.65%)
Hypotension	23 (1.58%)
Pyrexia	21 (1.44%)
	Show More
Dyspnoea	20 (1.37%)
Neutropenia	20 (1.37%)
Anaemia	18 (1.24%)
Arthralgia	18 (1.24%)
Decreased Appetite	18 (1.24%)
Constipation	17 (1.17%)
Pulmonary Embolism	17 (1.17%)
Hypokalaemia	16 (1.1%)
Abdominal Pain	15 (1.03%)
Asthenia	14 (.96%)
Epistaxis	13 (.89%)
Diarrhoea	12 (.82%)
Palpitations	12 (.82%)
Urinary Tract Infection	12 (.82%)
Blood Glucose Increased	11 (.76%)
Blood Sodium Decreased	11 (.76%)
Bone Pain	11 (.76%)
Liver Function Test Abnormal	11 (.76%)
Neutrophil Count Decreased	11 (.76%)
Rectal Haemorrhage	11 (.76%)
Aspartate Aminotransferase Increase...	10 (.69%)
Leukopenia	10 (.69%)
Platelet Count Decreased	10 (.69%)
Pleural Effusion	10 (.69%)
Bone Marrow Failure	9 (.62%)
Dizziness	9 (.62%)
Haematocrit Decreased	9 (.62%)
Mental Status Changes	9 (.62%)
Pancytopenia	9 (.62%)
Abdominal Tenderness	8 (.55%)
Atelectasis	8 (.55%)
Bacteraemia	8 (.55%)
Deep Vein Thrombosis	8 (.55%)
Headache	8 (.55%)
Malignant Neoplasm Progression	8 (.55%)
Muscular Weakness	8 (.55%)
Petechiae	8 (.55%)
Sepsis	8 (.55%)
Hyponatraemia	7 (.48%)
Malnutrition	7 (.48%)
Productive Cough	7 (.48%)
Septic Shock	7 (.48%)
Tachycardia	7 (.48%)
Acute Myeloid Leukaemia	6 (.41%)
Ascites	6 (.41%)
Blood Albumin Decreased	6 (.41%)
Blood Alkaline Phosphatase Increase...	6 (.41%)
Cold Sweat	6 (.41%)
Dysphagia	6 (.41%)
Hepatic Failure	6 (.41%)
Migraine	6 (.41%)
Neoplasm Progression	6 (.41%)
Peripheral Sensory Neuropathy	6 (.41%)
Refusal Of Treatment By Patient	6 (.41%)
Small Intestinal Obstruction	6 (.41%)
Squamous Cell Carcinoma	6 (.41%)
Back Pain	5 (.34%)
Blister	5 (.34%)
Cardio-respiratory Arrest	5 (.34%)
Convulsion	5 (.34%)
Disease Progression	5 (.34%)
Drug Ineffective	5 (.34%)
Gastrointestinal Haemorrhage	5 (.34%)
Hepatorenal Syndrome	5 (.34%)
Hypovolaemia	5 (.34%)
Infection	5 (.34%)
Left Ventricular Dysfunction	5 (.34%)
Metabolic Acidosis	5 (.34%)
Oesophagitis	5 (.34%)
Oxygen Saturation Decreased	5 (.34%)
Pneumocystis Jiroveci Pneumonia	5 (.34%)
Protein Total Decreased	5 (.34%)
Renal Failure	5 (.34%)
Respiratory Failure	5 (.34%)
Troponin Increased	5 (.34%)
Blood Lactate Dehydrogenase Increas...	4 (.27%)
Chest X-ray Abnormal	4 (.27%)
Colitis	4 (.27%)
Drug Toxicity	4 (.27%)
Dyspepsia	4 (.27%)
Enterocolitis	4 (.27%)
Gastritis	4 (.27%)
Haemoptysis	4 (.27%)
Hypophagia	4 (.27%)
Intestinal Obstruction	4 (.27%)
Non-cardiac Chest Pain	4 (.27%)
Pain In Jaw	4 (.27%)
Pelvic Pain	4 (.27%)
Pericardial Effusion	4 (.27%)
Thrombosis	4 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Abt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Abt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Abt

What are the most common Abt adverse events reported to the FDA?

Gastrointestinal Signs	103 (7.08%)
Hematology Investigations	97 (6.67%)
Infections - Pathogen Unspecified	77 (5.29%)
White Blood Cell	76 (5.22%)
Electrolyte And Fluid Balance Condi...	73 (5.02%)
Platelet	46 (3.16%)
Respiratory	44 (3.02%)
Anemias Nonhemolytic And Marrow Dep...	36 (2.47%)
Gastrointestinal Motility And Defec...	36 (2.47%)
Appetite And General Nutritional	29 (1.99%)
Gastrointestinal Hemorrhages	28 (1.92%)
	Show More
Hepatobiliary	26 (1.79%)
Miscellaneous And Site Unspecified ...	25 (1.72%)
Neurological	24 (1.65%)
Decreased And Nonspecific Blood Pre...	23 (1.58%)
Bacterial Infectious	22 (1.51%)
Cardiac Arrhythmias	22 (1.51%)
Gastrointestinal Inflammatory Condi...	22 (1.51%)
Body Temperature Conditions	21 (1.44%)
Joint	20 (1.37%)
Hepatic And Hepatobiliary	19 (1.31%)
Metabolic, Nutritional And Blood Ga...	18 (1.24%)
Enzyme	17 (1.17%)
Epidermal And Dermal Conditions	17 (1.17%)
Pulmonary Vascular	17 (1.17%)
Bone Disorders	16 (1.1%)
Embolism And Thrombosis	16 (1.1%)
Water, Electrolyte And Mineral	16 (1.1%)
Upper Respiratory Tract Disorders	15 (1.03%)
Headaches	14 (.96%)
Cardiac Disorder Signs	13 (.89%)
Lower Respiratory Tract Disorders	13 (.89%)
Gastrointestinal Stenosis And Obstr...	11 (.76%)
Pleural	11 (.76%)
Protein And Chemistry Analyses	11 (.76%)
Fungal Infectious	10 (.69%)
Lifestyle Issues	10 (.69%)
Musculoskeletal And Connective Tiss...	10 (.69%)
Renal Disorders	10 (.69%)
Skin Vascular Abnormalities	10 (.69%)
Metastases	9 (.62%)
Muscle	9 (.62%)
Psychiatric	9 (.62%)
Skin Appendage Conditions	9 (.62%)
Cardiac And Vascular Investigations	8 (.55%)
Gallbladder	8 (.55%)
Microbiology And Serology	8 (.55%)
Myocardial	8 (.55%)
Therapeutic And Nontherapeutic Effe...	8 (.55%)
Central Nervous System Vascular	7 (.48%)
Leukemias	7 (.48%)
Viral Infectious	7 (.48%)
Chemical Injury And Poisoning	6 (.41%)
Peripheral Neuropathies	6 (.41%)
Peritoneal And Retroperitoneal Cond...	6 (.41%)
Physical Examination Topics	6 (.41%)
Vascular	6 (.41%)
Acid-base	5 (.34%)
Gastrointestinal Conditions	5 (.34%)
Injuries	5 (.34%)
Pericardial	5 (.34%)
Respiratory And Pulmonary Investiga...	5 (.34%)
Seizures	5 (.34%)
Reproductive Tract	4 (.27%)
Skin Neoplasms Malignant And Unspec...	4 (.27%)
Sleep Disorders	4 (.27%)
Coronary Artery	3 (.21%)
Exocrine Pancreas Conditions	3 (.21%)
Gastrointestinal Ulceration And Per...	3 (.21%)
Inner Ear And Viiith Cranial Nerve	3 (.21%)
Reproductive Neoplasms Female Malig...	3 (.21%)
Urinary Tract Signs	3 (.21%)
Vascular Hemorrhagic	3 (.21%)
Arteriosclerosis, Stenosis, Vascula...	2 (.14%)
Bile Duct	2 (.14%)
Coagulopathies And Bleeding Diathes...	2 (.14%)
Deliria	2 (.14%)
Depressed Mood Disorders	2 (.14%)
Glucose Metabolism Disorders	2 (.14%)
Hemolyses And Related Conditions	2 (.14%)
Hepatobiliary Neoplasms Malignant A...	2 (.14%)
Hypothalamus And Pituitary Gland	2 (.14%)
Immunology And Allergy	2 (.14%)
Nervous System Neoplasms Malignant ...	2 (.14%)
Oral Soft Tissue Conditions	2 (.14%)
Renal And Urinary Tract Investigati...	2 (.14%)
Reproductive Neoplasms Male Maligna...	2 (.14%)
Respiratory And Mediastinal Neoplas...	2 (.14%)
Spleen, Lymphatic And Reticulendoth...	2 (.14%)
Vision	2 (.14%)
Abdominal Hernias And Other Abdomin...	1 (.07%)
Administration Site Reactions	1 (.07%)
Anxiety Disorders	1 (.07%)
Aural	1 (.07%)
Benign Neoplasms Gastrointestinal	1 (.07%)
Bone, Calcium, Magnesium And Phosph...	1 (.07%)
Breast Neoplasms Malignant And Unsp...	1 (.07%)
Bronchial Disorders	1 (.07%)
Cornification And Dystrophic Skin	1 (.07%)
Eating Disorders	1 (.07%)
Encephalopathies	1 (.07%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Abt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Abt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Abt According to Those Reporting Adverse Events

Why are people taking Abt, according to those reporting adverse events to the FDA?

Ovarian Cancer	50
Neoplasm	27
Dyslipidaemia	25
Glioblastoma Multiforme	22
Metastatic Malignant Melanoma	21
Hepatic Neoplasm Malignant	18
	Show More
Hepatitis C	16
Chronic Lymphocytic Leukaemia	9
Acute Myeloid Leukaemia	7
Prostate Cancer	5
Breast Cancer Metastatic	4
Prostate Cancer Metastatic	4
Psoriasis	3
Mixed Hyperlipidaemia	2
Medulloblastoma Recurrent	2
Non-small Cell Lung Cancer	2
Glioblastoma	2
Malignant Melanoma	2
Neoplasm Malignant	2
Hiv Infection	1
Lymphoma	1
Acute Myeloid Leukaemia Recurrent	1
Myeloma Recurrence	1
Chronic Lymphocytic Leukaemia Refra...	1
Leukaemia Recurrent	1
Chlamydial Infection	1
Product Used For Unknown Indication	1
Renal Cell Carcinoma	1

Abt Case Reports

What Abt safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Abt. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Abt.